Endoscopic Duodenal–Jejunal Bypass Liner Rapidly Improves Type 2 Diabetes
- 23 March 2013
- journal article
- research article
- Published by Springer Nature in Obesity Surgery
- Vol. 23 (9) , 1354-1360
Abstract
Bariatric procedures excluding the proximal small intestine improve glycemic control in type 2 diabetes within days. To gain insight into the mediators involved, we investigated factors regulating glucose homeostasis in patients with type 2 diabetes treated with the novel endoscopic duodenal–jejunal bypass liner (DJBL).Keywords
This publication has 35 references indexed in Scilit:
- Moderate Effect of Duodenal‐Jejunal Bypass Surgery on Glucose Homeostasis in Patients With Type 2 DiabetesObesity, 2012
- Loss of Inverse Relationship Between Pulsatile Insulin and Glucagon Secretion in Patients With Type 2 DiabetesDiabetes, 2011
- Bariatric surgery for diabetes: The International Diabetes Federation takes a positionJournal of Diabetes, 2011
- Differential Metabolic Impact of Gastric Bypass Surgery Versus Dietary Intervention in Obese Diabetic Subjects Despite Identical Weight LossScience Translational Medicine, 2011
- Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for pre-operative weight loss in bariatric surgerySurgical Endoscopy, 2008
- The Mechanism of Diabetes Control After Gastrointestinal Bypass Surgery Reveals a Role of the Proximal Small Intestine in the Pathophysiology of Type 2 DiabetesAnnals of Surgery, 2006
- Incretins, diabetes, and bariatric surgery: a reviewSurgery for Obesity and Related Diseases, 2005
- Effect of Laparoscopic Roux-En Y Gastric Bypass on Type 2 Diabetes MellitusAnnals of Surgery, 2003
- Global and societal implications of the diabetes epidemicNature, 2001
- GLUCAGON-LIKE PEPTIDE-1 7-36: A PHYSIOLOGICAL INCRETIN IN MANThe Lancet, 1987